Drug Shortage Report for KADIAN
| Report ID | 101180 |
| Drug Identification Number | 02184435 |
| Brand name | KADIAN |
| Common or Proper name | Morphine ER |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 20MG |
| Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 50BT |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2019-11-27 |
| Estimated end date | 2019-12-20 |
| Actual end date | 2019-12-19 |
| Shortage status | Resolved |
| Updated date | 2019-12-20 |
| Company comments | this was a duplicate record, now closed |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-12-20 | English | Compare |
| v6 | 2019-12-19 | French | Compare |
| v5 | 2019-12-19 | English | Compare |
| v4 | 2019-12-19 | French | Compare |
| v3 | 2019-12-19 | English | Compare |
| v2 | 2019-12-13 | French | Compare |
| v1 | 2019-12-13 | English | Compare |
Showing 1 to 7 of 7